Meet the 2022 Laureates: Henry M. Kronenberg, MD

Kronenberg, Henry (PE 2015)

Henry M. Kronenberg, MD

Fred Conrad Koch Lifetime Achievement Award

Henry M. Kronenberg, MD, has been chief of the Endocrine Unit at Massachusetts General Hospital in Boston, Mass., for over 32 years and is a professor of medicine at Harvard Medical School in Boston, Mass. 

His research group studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis, and the roles of osteoblast-lineage cells in hematopoiesis. His biggest accomplishment is bringing molecular biology to the bone and mineral field with the cloning of the parathyroid hormone. Kronenberg’s laboratory in recent years has used several genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone. 

President of the Endocrine Society from 2016 to 2017, Kronenberg has served on many other Society committees over the years, most notably as vice president, Basic Science, and as the Endocrine Society’s representative on the Federation of American Societies for Experimental Biology (FASEB) Board of Directors. 

How has the Endocrine Society supported your professional development/career journey?

The Endocrine Society was the first national society to welcome me, and, from that beginning, I have relied on the Endocrine Society to make me aware of new ways of thinking about endocrinology, both at the basic and clinical level. The annual meeting and journals, in particular, have defined current endocrinology for me. Equally importantly, the Endocrine Society has been the vehicle for my meeting people in the field from whom I have learned a lot and gained lasting friendships. I have been extremely grateful that the Society has provided me with leadership opportunities that gave me a unique chance to contribute to the broader missions of the Endocrine Society.

As a Laureate Award recipient, do you have any advice for those just beginning their careers?

I think that the key to a satisfying career is finding an area or activity about which you are passionate. As I started my career, I was amazed by the discovery of how hormones could control gene regulation in molecular detail. I badly wanted a chance to study this process, and I continue to be as excited now as I was then at the chance to participate in that effort.  If your job is to do what you love to do, then you’ve chosen the right career.  For me, the chance to combine endocrine research with the care of patients with hormone problems combines that passion for discovery with the sense of fulfillment that comes from trying to help others.

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…